Board of Directors

Russell L. Carson

NYGC Board Co-Chair Chairman, The Carson Family Charitable Trust. Co-Founder and General Partner, Welsh, Carson, Anderson & Stowe

Ivan G. Seidenberg

NYGC Board Co-Chair Former Chair and Chief Executive Officer, Verizon Communications

Dafna Bar-Sagi, PhD

Professor of Biochemistry and Molecular Pharmacology and Medicine, Senior Vice President and Vice Dean for Science, Chief Scientific Officer, NYU Langone Health 

Dennis S. Charney, MD

Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai President for Academic Affairs, Mount Sinai Health System

Augustine M.K. Choi, MD

Stephen and Suzanne Weiss Dean, Weill Cornell Medicine, Provost for Medical Affairs, Cornell University

Nicholas Donofrio

Fellow Emeritus, Executive Vice President Innovation and Technology, IBM (retired)

John B. Ehrenkranz

Chief Investment Officer, Ehrenkranz Partners

Anthony B. Evnin, PhD

Partner, Venrock

Lee Goldman, MD, MPH

Dean, Faculties of Health Sciences and Medicine and Chief Executive, Columbia University Irving Medical Center

John Havens

Partner & Non-Executive Chair, Napier Park Global Capital

Weslie R. Janeway

Director, Finistere Charitable Foundation

Richard P. Lifton, MD, PhD

President, The Rockefeller University

Edison T. Liu, MD

President and Chief Executive Officer, The Jackson Laboratory

Tom Maniatis, PhD

NYGC Scientific Director and Chief Executive Officer, Founding Director, Columbia Precision Medicine Initiative, Isidore S. Edelman Professor and Chair, Department of Biochemistry and Molecular Biophysics, Columbia University

Cheryl A. Moore

NYGC President and Chief Operating Officer

Herbert Pardes, MD

Executive Vice Chairman of the Board of Trustees, New York-Presbyterian Hospital

Frank E. Richardson, MA, JD

Co-Founder & Senior Advisory Partner, Sentinel Capital Partners

Frank V. Sica

Partner, Tailwind Capital

Jim Simons, PhD

Chair, Simons Foundation Chair, Euclidean Capital, LLC Board Chair, Renaissance Technologies

Steven D. Singer

Partner, WilmerHale

Samuel L. Stanley Jr., MD

President, Stony Brook University

Bruce Stillman, PhD

President and Chief Executive Officer, Cold Spring Harbor Laboratory

Craig B. Thompson, MD

President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center

Gordon F. Tomaselli, MD, FAHA, FACC, FHRS

The Stanley and Marilyn M. Katz Dean, Albert Einstein College of Medicine, Executive Vice President and Chief Academic Officer, Montefiore Medicine

Kevin J. Tracey, MD

President and Chief Executive Officer, Feinein Institute for Medical Research, Professor of Neurosurgery and Molecular Medicine, Zucker school of Medicine at Hofstra/Northwel

Senior Management

Tom Maniatis, PhD

Scientific Director and Chief Executive Officer
  • Neurodegenerative diseases

Cheryl A. Moore

NYGC President and Chief Operating Officer

Carol Ashe

Chief Business Officer

Ana Bastiani-Posner

Senior Vice President, Finance and Administration

Soren Germer, PhD

Senior Vice President, Genome Technologies
  • Computational biology

Kathleen Kearns

Vice President, Development & Communications

Elizabeth O’Brien

Vice President and General Counsel

Faculty and Senior Scientists

Scientific Director and Core Faculty

Tom Maniatis, PhD

Scientific Director
  • Neurodegenerative diseases

Marcin Imielinski, MD, PhD

Core Faculty Member
  • Cancer

Ivan Iossifov, PhD

Core Faculty Member, Assistant Investigator
  • Neuropsychiatric Diseases

David A. Knowles, PhD

Core Faculty Member
  • Functional genomics

Dan A. Landau, MD, PhD

Core Faculty Member
  • Cancer

Tuuli Lappalainen, PhD

Core Faculty Member
  • Functional genomics

Hemali Phatnani, PhD

Director of the Center for Genomics of Neurodegenerative Disease
  • Neurodegenerative diseases

Neville Sanjana, PhD

Core Faculty Member
  • Cancer
  • Neuropsychiatric diseases

Rahul Satija, PhD

Core Faculty Member
  • Functional Genomics

Senior Scientists

Toby Bloom, PhD

Senior Director of Informatics, Strategic Genomic Analysis
  • Computational biology

Soren Germer, PhD

Senior Vice President, Genome Technologies
  • Computational biology

Nico Robine, PhD

Assistant Director, Computational Biology
  • Computational biology

Peter Smibert, PhD

Manager, Technology Innovation
  • Technology Innovation

Michael Zody, PhD

Scientific Director of Computational Biology
  • Computational biology

Associate Members

Greg Hannon, PhD

Senior Associate Core Member
  • Cancer

Simon Tavaré, PhD

Senior Associate Core Member
  • Cancer

Harold Varmus, MD

Senior Associate Core Member
  • Cancer

Mike Wigler, PhD

Senior Associate Core Member
  • Neuropsychiatric diseases

Evan Eichler, PhD

Associate Member
  • Neuropsychiatric diseases

Affiliate Members

The NYGC provides Affiliate Memberships to external academic researchers who have a significant interest in and commitment to the scientific life and work of the NYGC, and will contribute to and benefit from the NYGC’s mission.

Researchers who hold primary academic and/or clinical appointments at other institutions, including Institutional Founding Members and Institutional Associate Members, are eligible to be considered for an appointment as Affiliate Members.

The NYGC currently has 67 Affiliate Members, hailing from 14 academic institutions across the country. Please email Affiliate affiliate@nygenome.org if you are interested in applying to the program.

NYGC AFFILIATE MEMBERS

Cory Abate-Shen, PhD,
Columbia University
Michael Berger, PhD,
Memorial Sloan Kettering Cancer Center
Richard Bonneau, PhD,
New York University
Joseph Buxbaum, PhD,
Mount Sinai
Andrea Califano, PhD,
Columbia University
Lewis Cantley, PhD,
Weill Cornell Medicine
Aravinda Chakravarti, PhD,
New York University
Alexander Charney, MD, PhD,
Mount Sinai
Wendy Chung, MD, PhD,
Columbia University
Christopher Cunniff, MD,
Weill Cornell Medicine
Philip De Jager, MD, PhD,
Columbia University
Olivier Elemento, PhD,
Weill Cornell Medicine
Eleazar Eskin, PhD,
UCLA
Howard A. Fine, MD,
Weill Cornell Medicine
Fieke Froeling, MD, PhD,
Cold Spring Harbor Laboratory
Kevin Gardner, MD, PhD,
Columbia University
Jellert Gaublomme, PhD,
Columbia University
Thomas R. Gingeras, PhD,
Cold Spring Harbor Laboratory
Alison Goate, DPhil,
Mount Sinai
John Greally, PhD,
Albert Einstein College of Medicine
Benjamin Greenbaum, PhD,
Mount Sinai
Cheryl Y. Hayashi, PhD,
American Museum of Natural History
George Hripcsak, MD,
Columbia University
Marko Jovanovic, PhD,
Columbia University
Eimear Kenny, PhD,
Mount Sinai
Ekta Khurana, PhD,
Weill Cornell Medicine
Jennie Kline, PhD,
Columbia University
Andrew Kung, MD, PhD,
Memorial Sloan Kettering Cancer Center
Marc Ladanyi, MD,
Memorial Sloan Kettering Cancer Center
Ross Levine, MD,
Memorial Sloan Kettering Cancer Center
Steven Lipkin, MD, PhD,
Weill Cornell Medicine
David Lyden, MD, PhD,
Weill Cornell Medicine
Christopher Mason, PhD,
Weill Cornell Medicine
W. Richard McCombie, PhD,
Cold Spring Harbor Laboratory
Ari MelnIck, MD,
Weill Cornell Medicine
Vilas Menon, PhD,
Columbia University
JJ Miranda, PhD,
Barnard College
Bud Mishra, PhD,
New York University
Parvathi A. Myer, MD,
Albert Einstein College of Medicine
Benjamin G. Neel, MD, PhD,
New York University
Kenneth Offit, MD
Memorial Sloan Ketting Cancer Center
William Oh, MD,
Mount Sinai
Ramon Parsons, MD, PhD,
Mount Sinai
Chiraag D. Patel, MD,
Stony Brook University
Scott Powers, PhD,
Stony Brook University
Molly Przeworski, PhD,
Columbia University
Raul Rabadan, PhD,
Columbia University
Ben Raphael, PhD,
Princeton University
M. Elizabeth Ross, MD, PhD,
Weill Cornell Medicine
Kevin A Roth, MD, PhD,
Columbia University
Panos Roussos, MD, PhD,
Mount Sinai
Charles Sawyers, MD,
Memorial Sloan Kettering Cancer Center
Nikolaus Schultz, PhD,
Memorial Sloan Kettering Cancer Center
Sohrab P. Shah, PhD,
Memorial Sloan Kettering Cancer Center
Yufeng Shen, PhD,
Columbia University
Adam Siepel, PhD,
Cold Spring Harbor Laboratory
Jane Skok, PhD,
New York University
Barry Sleckman, MD, PhD,
Weill Cornell Medicine
Sohail Tavazoie, MD, PhD,
The Rockefeller University
Barry S. Taylor, PhD,
Memorial Sloan Kettering Cancer Center
David Tuveson, MD, PhD,
Cold Spring Harbor Laboratory
Krishna Veeramah, PhD,
Stony Brook University
Thomas Vierbuchen, PhD,
Memorial Sloan Kettering Cancer Center
Julia Wattacheril, MD,
Columbia University
George Weinstock, PhD,
The Jackson Laboratory
Itai Yanai, PhD,
New York University
Chaolin Zhang, PhD,
Columbia University

Scientific Working Groups

The NYGC has established scientific working groups with the objective of bringing together NYGC researchers and the scientific community to advance disease-based research in areas where our strengths and experience can make a significant difference.

  • Neurodegenerative Diseases Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center.
  • Neuropsychiatric Diseases Working Group
  • Computational Cancer Genomics Working Group, led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center.
  • Enabling Innovation Working Group
  • Population Genomics Working Group, led by Adam Siepel, PhD, Cold Spring Harbor Laboratory, and Eimear Kenny, PhD, Icahn School of Medicine at Mount Sinai.